Byeong-Bae Park

557 total citations
24 papers, 431 citations indexed

About

Byeong-Bae Park is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Byeong-Bae Park has authored 24 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in Byeong-Bae Park's work include Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Viral-associated cancers and disorders (5 papers). Byeong-Bae Park is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Viral-associated cancers and disorders (5 papers). Byeong-Bae Park collaborates with scholars based in South Korea, United States and South Africa. Byeong-Bae Park's co-authors include Won Seog Kim, In Gyu Hwang, Kihyun Kım, Sang Cheol Lee, Ho Yeong Lim, Sarah Park, Keunchil Park, Young Hyeh Ko, Won Ki Kang and Jin Seok Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Byeong-Bae Park

23 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byeong-Bae Park South Korea 11 184 141 126 120 110 24 431
Michela Cerno Italy 14 234 1.3× 110 0.8× 372 3.0× 158 1.3× 149 1.4× 32 653
Raffaella Stocchi Italy 12 171 0.9× 86 0.6× 267 2.1× 76 0.6× 67 0.6× 20 461
Elizabeth Margolskee United States 13 166 0.9× 64 0.5× 119 0.9× 73 0.6× 174 1.6× 35 494
Vivek A. Bhadri Australia 13 187 1.0× 160 1.1× 84 0.7× 70 0.6× 63 0.6× 35 559
Chang‐Tsu Yuan Taiwan 13 168 0.9× 82 0.6× 40 0.3× 55 0.5× 137 1.2× 54 424
Niyati Bhagwati United States 13 227 1.2× 88 0.6× 281 2.2× 156 1.3× 48 0.4× 20 560
Barbara H. Burke United States 3 288 1.6× 44 0.3× 98 0.8× 77 0.6× 117 1.1× 7 433
Jay E. Gold United States 13 235 1.3× 52 0.4× 50 0.4× 73 0.6× 151 1.4× 21 418
Anne Marie Gonzales United States 9 180 1.0× 36 0.3× 224 1.8× 167 1.4× 60 0.5× 13 469
Natacha Maillard France 12 109 0.6× 67 0.5× 286 2.3× 56 0.5× 44 0.4× 31 409

Countries citing papers authored by Byeong-Bae Park

Since Specialization
Citations

This map shows the geographic impact of Byeong-Bae Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byeong-Bae Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byeong-Bae Park more than expected).

Fields of papers citing papers by Byeong-Bae Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byeong-Bae Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byeong-Bae Park. The network helps show where Byeong-Bae Park may publish in the future.

Co-authorship network of co-authors of Byeong-Bae Park

This figure shows the co-authorship network connecting the top 25 collaborators of Byeong-Bae Park. A scholar is included among the top collaborators of Byeong-Bae Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byeong-Bae Park. Byeong-Bae Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Byeong-Bae, et al.. (2022). Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia. International Journal of Molecular Sciences. 23(20). 12708–12708. 10 indexed citations
2.
Suh, Cheolwon, Byeong-Bae Park, & Won Seog Kim. (2017). The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective. Blood Research. 52(1). 3–3. 2 indexed citations
3.
4.
Lee, Mark Hong, Inho Kim, Yeo-Kyeoung Kim, et al.. (2015). Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation. Blood Research. 50(3). 160–160. 3 indexed citations
5.
Lee, Mark Hong, Yunsuk Choi, Inho Kim, et al.. (2014). R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma. Blood Research. 49(2). 107–107. 10 indexed citations
6.
Byun, Young Jae, et al.. (2014). A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow. Blood Research. 49(2). 127–127. 7 indexed citations
7.
Sohn, Won, Byung Chul Yoon, Byeong-Bae Park, & Chan Kum Park. (2012). Duodenal involvement in multiple myeloma. Digestive and Liver Disease. 44(6). 533–533. 1 indexed citations
8.
Paik, Seung Sam, et al.. (2011). A Case of Gastric Adenocarcinoma Arising from Ectopic Pancreas showing Gastric Outlet Obstruction. Clinical Endoscopy. 42(6). 373–377. 1 indexed citations
9.
Park, Byeong-Bae, Ji Sun Lee, Sun-Min Kim, et al.. (2009). A Case of Kikuchi Fujimoto's Disease Accompanied by Hemophagocytic Lymphohistiocytosis. The Korean Journal of Hematology. 44(4). 325–325. 2 indexed citations
10.
Park, Byeong-Bae, Young‐Hyuck Im, In Gyu Hwang, et al.. (2008). Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. Investigational New Drugs. 26(4). 387–392. 15 indexed citations
11.
Ahn, Myung‐Ju, Byeong-Bae Park, Jin Seok Ahn, et al.. (2008). Are There Any Ethnic Differences in Molecular Predictors of Erlotinib Efficacy in Advanced Non-Small Cell Lung Cancer?. Clinical Cancer Research. 14(12). 3860–3866. 47 indexed citations
12.
Lee, Yuna, Keun‐Wook Lee, Jee-Hyun Kim, et al.. (2008). Epstein-Barr Virus-Positivity in Tumor has no Correlation with the Clinical Outcomes of Patients with Angioimmunoblastic T-cell Lymphoma. The Korean Journal of Internal Medicine. 23(1). 30–30. 16 indexed citations
13.
Lee, Hyeran, Byeong-Bae Park, In Gyu Hwang, et al.. (2007). Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Annals of Hematology. 86(7). 493–8. 113 indexed citations
14.
Hwang, In Gyu, Myung‐Ju Ahn, Byeong-Bae Park, et al.. (2007). C3-06: ERCC1 expression as a predictive marker in stage IIIA, N2 positive non-small cell lung cancer patients treated with neoadjuvant concurrent chemoradiotherapy followed by surgery. Journal of Thoracic Oncology. 2(8). S367–S367. 3 indexed citations
15.
Jung, Chul Won, Jeeyun Lee, Byeong-Bae Park, et al.. (2007). Postremission therapy for acute myeloid leukemia in the first remission. Leukemia & lymphoma. 48(5). 937–943. 4 indexed citations
16.
Park, Sarah, Myung‐Ju Ahn, Jin Seok Ahn, et al.. (2007). Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer. Lung Cancer. 58(1). 116–122. 16 indexed citations
17.
Hwang, In Gyu, Keon Hee Yoo, Soo Hyun Lee, et al.. (2007). Clinicopathologic Features and Treatment Outcomes in Malignant Lymphoma of Pediatric and Young Adult Patients in Korea: Comparison of Korean All-Ages Group and Western Younger Age Group. Clinical Lymphoma & Myeloma. 7(9). 580–586. 10 indexed citations
18.
Uhm, Ji Eun, Ho Yeong Lim, Won Seog Kim, et al.. (2007). Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract. Neoplasia. 9(1). 18–22. 29 indexed citations
19.
Park, Byeong-Bae, Joon Oh Park, Hojoong Kim, et al.. (2006). Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?. Lung Cancer. 53(3). 323–330. 19 indexed citations
20.
Lim, Do Hyoung, Young‐Hyuck Im, Sang Hoon Ji, et al.. (2004). Esophageal Squamous Cell Carcinoma Recurring as a Solitary Renal Mass. Cancer Research and Treatment. 36(4). 271–271. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Cerno Breakdown of academic impact, for papers by Raffaella Stocchi Breakdown of academic impact, for papers by Elizabeth Margolskee Breakdown of academic impact, for papers by Vivek A. Bhadri Breakdown of academic impact, for papers by Chang‐Tsu Yuan Breakdown of academic impact, for papers by Niyati Bhagwati Breakdown of academic impact, for papers by Barbara H. Burke Breakdown of academic impact, for papers by Jay E. Gold Breakdown of academic impact, for papers by Anne Marie Gonzales Breakdown of academic impact, for papers by Natacha Maillard
Rankless by CCL
2026